National Institute for Health and Care Excellence1d
New drug approved for inherited clotting disorder, offering simpler dosing and enhanced quality of life.
NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in people aged 2 and over with severe haemophilia A. These cookies remember ...
National Institute for Health and Care Excellence5d
NICE’s prioritisation process explained – what healthtech developers need to know
If you're developing a healthtech product, understanding NICE's priorities is crucial. For 2024/25, NICE is focussing on innovations addressing: ...
National Institute for Health and Care Excellence4d
Early and locally advanced breast cancer: diagnosis and management - Neoadjuvant chemotherapy and ovarian function suppression (update)
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder. Not eligible? Contact the stakeholder organisation that most closely represents your interests and ...